Low-dose radiation prevents type 1 diabetes-induced cardiomyopathy via activation of AKT mediated anti-apoptotic and anti-oxidant effects

Journal of Cellular and Molecular Medicine

Volumn 20, Issue 7, 2016, Pages 1352-1366

  Zhang, Fangfang ^a   Lin, Xiufei ^a   Yu, Lechu ^a   Li, Weihua ^b   Qian, Dingliang ^b   Cheng, Peng ^a   He, Luqing ^a   Yang, Hong ^a   Zhang, Chi ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b THE THIRD AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

apoptosis; cardiac hypertrophy remodelling; diabetic cardiomyopathy; low dose radiation; oxidative stress

Indexed keywords

CASPASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOMYOPATHY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GENE MUTATION; GENE SILENCING; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KINASE ASSAY; LIPID OXIDATION; LOW ENERGY RADIATION; MALE; MORPHOLOGICAL ADAPTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; TUNEL ASSAY; WESTERN BLOTTING; X RAY;

EID: 84977524203     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12823     Document Type: Article

References (56)

1. Feng B, Chen S, George B, et al. miR133a regulates cardiomyocyte hypertrophy in diabetes. Diabetes Metab Res Rev. 2010; 26: 40–9.
2. Chang SH, Liu CJ, Kuo CH, et al. Garlic oil alleviates MAPKs- and IL-6-mediated diabetes-related cardiac hypertrophy in STZ-induced DM rats. Evid Based Complement Alternat Med. 2011; 2011: 950150.
3. Cox EJ, Marsh SA. A systematic review of fetal genes as biomarkers of cardiac hypertrophy in rodent models of diabetes. PLoS ONE. 2014; 9: e92903.
4. Adeghate E. Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: a short review. Mol Cell Biochem. 2004; 261: 187–91.
5. van Empel VP, De Windt LJ. Myocyte hypertrophy and apoptosis: a balancing act. Cardiovasc Res. 2004; 63: 487–99.
6. Wollert KC, Drexler H. Regulation of cardiac remodeling by nitric oxide: focus on cardiac myocyte hypertrophy and apoptosis. Heart Fail Rev. 2002; 7: 317–25.
7. Maulik SK, Kumar S. Oxidative stress and cardiac hypertrophy: a review. Toxicol Mech Methods. 2012; 22: 359–66.
8. Calabrese EJ, Baldwin LA. Hormesis: the dose-response revolution. Annu Rev Pharmacol Toxicol. 2003; 43: 175–97.
9. Cuttler JM, Pollycove M. Nuclear energy and health: and the benefits of low-dose radiation hormesis. Dose Response. 2009; 7: 52–89.
10. Shao M, Yu L, Zhang F, et al. Additive protection by LDR and FGF21 treatment against diabetic nephropathy in type 2 diabetes model. Am J Physiol Endocrinol Metab. 2015; 309: E45–54.
11. Shao M, Lu X, Cong W, et al. Multiple low-dose radiation prevents type 2 diabetes-induced renal damage through attenuation of dyslipidemia and insulin resistance and subsequent renal inflammation and oxidative stress. PLoS ONE. 2014; 9: e92574.
12. Xing X, Zhang C, Shao M, et al. Low-dose radiation activates Akt and Nrf2 in the kidney of diabetic mice: a potential mechanism to prevent diabetic nephropathy. Oxid Med Cell Longev. 2012; 2012: 291087.
13. Zhang C, Tan Y, Guo W, et al. Attenuation of diabetes-induced renal dysfunction by multiple exposures to low-dose radiation is associated with the suppression of systemic and renal inflammation. Am J Physiol Endocrinol Metab. 2009; 297: E1366–77.
14. Zhang C, Jin S, Guo W, et al. Attenuation of diabetes-induced cardiac inflammation and pathological remodeling by low-dose radiation. Radiat Res. 2011; 175: 307–21.
15. Ares-Carrasco S, Picatoste B, Benito-Martin A, et al. Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes. Am J Physiol Heart Circ Physiol. 2009; 297: H2109–19.
16. Westermann D, Van Linthout S, Dhayat S, et al. Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol. 2007; 102: 500–7.
17. Westermann D, Van Linthout S, Dhayat S, et al. Cardioprotective and anti-inflammatory effects of interleukin converting enzyme inhibition in experimental diabetic cardiomyopathy. Diabetes. 2007; 56: 1834–41.
18. Westermann D, Rutschow S, Jager S, et al. Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism. Diabetes. 2007; 56: 641–6.
19. Shu X, Yang Z, Li ZH, et al. Helicobacter pylori infection activates the Akt-Mdm2-p53 signaling pathway in gastric epithelial cells. Dig Dis Sci. 2015; 60: 876–86.
20. Dung TD, Day CH, Binh TV, et al. PP2A mediates diosmin p53 activation to block HA22T cell proliferation and tumor growth in xenografted nude mice through PI3K-Akt-MDM2 signaling suppression. Food Chem Toxicol. 2012; 50: 1802–10.
21. Fenouille N, Puissant A, Tichet M, et al. SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival. Oncogene. 2011; 30: 4887–900.
22. Li B, Cui W, Tan Y, et al. Zinc is essential for the transcription function of Nrf2 in human renal tubule cells in vitro and mouse kidney in vivo under the diabetic condition. J Cell Mol Med. 2014; 18: 895–906.
23. Zhang C, Lu X, Tan Y, et al. Diabetes-induced hepatic pathogenic damage, inflammation, oxidative stress, and insulin resistance was exacerbated in zinc deficient mouse model. PLoS ONE. 2012; 7: e49257.
24. Padiya R, Chowdhury D, Borkar R, et al. Garlic attenuates cardiac oxidative stress via activation of PI3K/AKT/Nrf2-Keap1 pathway in fructose-fed diabetic rat. PLoS ONE. 2014; 9: e94228.
25. Cui W, Bai Y, Luo P, et al. Preventive and therapeutic effects of MG132 by activating Nrf2-ARE signaling pathway on oxidative stress-induced cardiovascular and renal injury. Oxid Med Cell Longev. 2013; 2013: 306073.
26. Bai Y, Cui W, Xin Y, et al. Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation. J Mol Cell Cardiol. 2013; 57: 82–95.
27. Zhang C, Huang Z, Gu J, et al. Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway. Diabetologia. 2015; 58: 1937–48.
28. Luo J, Hill BG, Gu Y, et al. Mechanisms of acrolein-induced myocardial dysfunction: implications for environmental and endogenous aldehyde exposure. Am J Physiol Heart Circ Physiol. 2007; 293: H3673–84.
29. Tan Y, Li X, Prabhu SD, et al. Angiotensin II plays a critical role in alcohol-induced cardiac nitrative damage, cell death, remodeling, and cardiomyopathy in a protein kinase C/nicotinamide adenine dinucleotide phosphate oxidase-dependent manner. J Am Coll Cardiol. 2012; 59: 1477–86.
30. Cai L, Wang Y, Zhou G, et al. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J Am Coll Cardiol. 2006; 48: 1688–97.
31. Cai L, Li W, Wang G, et al. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes. 2002; 51: 1938–48.
32. Cai L, Wang J, Li Y, et al. Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy. Diabetes. 2005; 54: 1829–37.
33. Zhang Y, Wei L, Sun D, et al. Tanshinone IIA pretreatment protects myocardium against ischaemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway in diabetic rats. Diabetes Obes Metab. 2010; 12: 316–22.
34. Whittington HJ, Harding I, Stephenson CI, et al. Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling. Cardiovasc Res. 2013; 99: 694–704.
35. Rubler S, Dlugash J, Yuceoglu YZ, et al. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972; 30: 595–602.
36. Wang Y, Sun W, Du B, et al. Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-kappaB. Am J Physiol Heart Circ Physiol. 2013; 304: H567–78.
37. Guan SJ, Ma ZH, Wu YL, et al. Long-term administration of fasudil improves cardiomyopathy in streptozotocin-induced diabetic rats. Food Chem Toxicol. 2012; 50: 1874–82.
38. Cai L. Research of the adaptive response induced by low-dose radiation: where have we been and where should we go? Hum Exp Toxicol. 1999; 18: 419–25.
39. Cai L, Liu SZ. Induction of cytogenetic adaptive response of somatic and germ cells in vivo and in vitro by low-dose X-irradiation. Int J Radiat Biol. 1990; 58: 187–94.
40. Liu G, Gong P, Bernstein LR, et al. Apoptotic cell death induced by low-dose radiation in male germ cells: hormesis and adaptation. Crit Rev Toxicol. 2007; 37: 587–605.
41. Jiang H, Li W, Li X, et al. Low-dose radiation induces adaptive response in normal cells, but not in tumor cells: in vitro and in vivo studies. J Radiat Res. 2008; 49: 219–30.
42. Jiang H, Xu Y, Li W, et al. Low-dose radiation does not induce proliferation in tumor cells in vitro and in vivo. Radiat Res. 2008; 170: 477–87.
43. Chaanine AH, Hajjar RJ. AKT signalling in the failing heart. Eur J Heart Fail. 2011; 13: 825–9.
44. Shiojima I, Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res. 2002; 90: 1243–50.
45. Shiojima I, Walsh K. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev. 2006; 20: 3347–65.
46. Zhou S, Yin X, Zheng Y, et al. Metallothionein prevents intermittent hypoxia-induced cardiac endoplasmic reticulum stress and cell death likely via activation of Akt signaling pathway in mice. Toxicol Lett. 2014; 227: 113–23.
47. Tan Y, Li Y, Xiao J, et al. A novel CXCR4 antagonist derived from human SDF-1beta enhances angiogenesis in ischaemic mice. Cardiovasc Res. 2009; 82: 513–21.
48. Wang M, Sun GB, Zhang JY, et al. Elatoside C protects the heart from ischaemia/reperfusion injury through the modulation of oxidative stress and intracellular Ca(2)(+) homeostasis. Int J Cardiol. 2015; 185: 167–76.
49. Matsui T, Li L, del Monte F, et al. Adenoviral gene transfer of activated phosphatidylinositol 3′-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation. 1999; 100: 2373–9.
50. Matsui T, Tao J, del Monte F, et al. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation. 2001; 104: 330–5.
51. Taniyama Y, Walsh K. Elevated myocardial Akt signaling ameliorates doxorubicin-induced congestive heart failure and promotes heart growth. J Mol Cell Cardiol. 2002; 34: 1241–7.
52. Worou ME, Belmokhtar K, Bonnet P, et al. Hemin decreases cardiac oxidative stress and fibrosis in a rat model of systemic hypertension via PI3K/Akt signalling. Cardiovasc Res. 2011; 91: 320–9.
53. Han CT, Schoene NW, Lei KY. Influence of zinc deficiency on Akt-Mdm2-p53 and Akt-p21 signaling axes in normal and malignant human prostate cells. Am J Physiol Cell Physiol. 2009; 297: C1188–99.
54. Pinar B, Lara PC, Lloret M, et al. Radiation-induced DNA damage as a predictor of long-term toxicity in locally advanced breast cancer patients treated with high-dose hype-rfractionated radical radiotherapy. Radiat Res. 2007; 168: 415–22.
55. Hellman B, Brodin D, Andersson M, et al. Radiation-induced DNA-damage and gene expression profiles in human lung cancer cells with different radiosensitivity. Exp Oncol. 2005; 27: 102–7.
56. Popanda O, Ebbeler R, Twardella D, et al. Radiation-induced DNA damage and repair in lymphocytes from breast cancer patients and their correlation with acute skin reactions to radiotherapy. Int J Radiat Oncol Biol Phys. 2003; 55: 1216–25.